Company Overview of DAN Immunotherapy Ltd.
DAN Immunotherapy, Ltd. develops therapeutic cancer vaccines. It operates in the immunotherapy pharmaceutical market section. The company uses bioinformatics-designed multiepitope polypeptide technology, suited for the vaccination of cancer patients. DAN Immunotherapy was founded in 2004 and is based in Kiryat Shmona, Israel.
Southern Industrial Zone
Kiryat Shmona, 11013
Founded in 2004
972 4 681 8808
972 4 681 8806
Key Executives for DAN Immunotherapy Ltd.
Similar Private Companies By Industry
|Abital Pharma Pipelines Ltd.||Middle East/Africa|
|Active PX Ltd.||Middle East/Africa|
|Advanced Inhalation Technology Ltd.||Middle East/Africa|
|Alvit LCS Pharma Ltd||Middle East/Africa|
|Angio B Ltd.||Middle East/Africa|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|Tax Management Inc||United States|
|John F. Kennedy Center For The Performing Arts||United States|
|NYC2012, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact DAN Immunotherapy Ltd., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.